Moderna
MRNA
#1471
Rank
HK$90.81 B
Marketcap
HK$235.39
Share price
-2.23%
Change (1 day)
-68.68%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -HK$18.21 Billion

According to Moderna 's latest financial reports the company's current earnings are HK$5.05 Billion. In 2023 the company made an earning of -HK$30.36 Billion a decrease over its 2022 earnings that were of HK$74.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$18.21 Billion-40.02%
2023 -HK$30.36 Billion-140.65%
2022 HK$74.68 B-27.81%
2021 HK$103.44 B-1911.15%
2020 -HK$5.72 Billion44.7%
2019 -HK$3.95 Billion28.63%
2018 -HK$3.07 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.33 Billion-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$116.43 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.33 Billion-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.84 Billion-89.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$106.06 B-685.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$4.67 Billion-74.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$135.63 B-848.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.92 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA